InMode (INMD) Competitors $14.26 +0.01 (+0.07%) Closing price 04:00 PM EasternExtended Trading$14.30 +0.04 (+0.25%) As of 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INMD vs. INSP, NVST, PRCT, LIVN, WRBY, ENOV, NVCR, LMAT, EYE, and CNMDShould you be buying InMode stock or one of its competitors? The main competitors of InMode include Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), Enovis (ENOV), NovoCure (NVCR), LeMaitre Vascular (LMAT), National Vision (EYE), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. InMode vs. Its Competitors Inspire Medical Systems Envista PROCEPT BioRobotics LivaNova Warby Parker Enovis NovoCure LeMaitre Vascular National Vision CONMED InMode (NASDAQ:INMD) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership. Which has more volatility & risk, INMD or INSP? InMode has a beta of 1.95, indicating that its share price is 95% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500. Is INMD or INSP more profitable? InMode has a net margin of 44.79% compared to Inspire Medical Systems' net margin of 7.92%. InMode's return on equity of 17.17% beat Inspire Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets InMode44.79% 17.17% 15.20% Inspire Medical Systems 7.92%10.00%8.68% Does the media prefer INMD or INSP? In the previous week, InMode and InMode both had 13 articles in the media. Inspire Medical Systems' average media sentiment score of 1.21 beat InMode's score of 0.59 indicating that Inspire Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 10 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, INMD or INSP? InMode has higher earnings, but lower revenue than Inspire Medical Systems. InMode is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInMode$394.82M2.28$181.27M$2.336.12Inspire Medical Systems$802.80M4.68$53.51M$2.1758.71 Do institutionals & insiders hold more shares of INMD or INSP? 68.0% of InMode shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 6.9% of InMode shares are held by insiders. Comparatively, 4.1% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts rate INMD or INSP? InMode presently has a consensus target price of $18.54, indicating a potential upside of 30.03%. Inspire Medical Systems has a consensus target price of $210.27, indicating a potential upside of 65.04%. Given Inspire Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe Inspire Medical Systems is more favorable than InMode.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InMode 0 Sell rating(s) 7 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.13Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73 SummaryInspire Medical Systems beats InMode on 8 of the 15 factors compared between the two stocks. Get InMode News Delivered to You Automatically Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INMD vs. The Competition Export to ExcelMetricInModeMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$900.73M$10.27B$5.52B$9.32BDividend YieldN/A2.07%4.25%4.05%P/E Ratio6.1216.9728.1519.68Price / Sales2.2829.20438.33100.29Price / Cash7.8122.2335.5357.53Price / Book1.413.598.235.67Net Income$181.27M$233.40M$3.23B$257.51M7 Day Performance-6.37%-2.69%-0.01%0.52%1 Month Performance6.18%1.85%5.61%8.84%1 Year Performance-25.18%-18.53%26.52%14.18% InMode Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INMDInMode4.0623 of 5 stars$14.26+0.1%$18.54+30.0%-20.1%$900.73M$394.82M6.12480News CoverageINSPInspire Medical Systems4.8615 of 5 stars$127.11-1.1%$211.91+66.7%-7.8%$3.75B$802.80M58.581,246News CoveragePositive NewsAnalyst ForecastNVSTEnvista3.3655 of 5 stars$19.66-3.6%$20.23+2.9%+24.2%$3.33B$2.51B-3.0112,300Analyst RevisionPRCTPROCEPT BioRobotics2.4813 of 5 stars$56.97-1.6%$90.00+58.0%-13.2%$3.15B$224.50M-33.51430News CoverageAnalyst ForecastAnalyst RevisionLIVNLivaNova3.074 of 5 stars$45.58-1.2%$59.29+30.1%-16.5%$2.49B$1.25B-11.142,900News CoveragePositive NewsWRBYWarby Parker2.445 of 5 stars$21.40-3.8%$22.88+6.9%+40.5%$2.24B$795.09M-178.333,780Positive NewsENOVEnovis2.4562 of 5 stars$33.03-1.8%$58.00+75.6%-30.9%$1.89B$2.15B-2.377,367NVCRNovoCure3.5306 of 5 stars$16.89-4.6%$32.83+94.4%-6.7%$1.88B$605.22M-11.191,488LMATLeMaitre Vascular2.6164 of 5 stars$82.98-1.7%$97.83+17.9%-4.7%$1.87B$219.86M41.91490News CoveragePositive NewsEYENational Vision2.8452 of 5 stars$23.33-2.4%$18.67-20.0%+99.2%$1.84B$1.82B-70.6913,411CNMDCONMED4.3052 of 5 stars$51.86-4.5%$62.20+19.9%-28.7%$1.60B$1.31B13.653,900News Coverage Related Companies and Tools Related Companies INSP Alternatives NVST Alternatives PRCT Alternatives LIVN Alternatives WRBY Alternatives ENOV Alternatives NVCR Alternatives LMAT Alternatives EYE Alternatives CNMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INMD) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INMD Stock Alerts